Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2014 | 04-2014 | 01-2014 | 10-2013 | 07-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,980 | 2,832 | 4,386 | 2,482 | 4,493 |
| Receivables | 343 | 183 | 348 | 474 | 559 |
| TOTAL | $7,405 | $3,138 | $4,942 | $3,067 | $5,191 |
| Non-Current Assets | |||||
| PPE Net | 448 | 525 | 576 | 623 | 677 |
| TOTAL | $448 | $525 | $576 | $623 | $677 |
| Total Assets | $7,853 | $3,663 | $5,518 | $3,690 | $5,868 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 566 | 246 | 218 | 554 | 304 |
| Accrued Expenses | 476 | 400 | 286 | 308 | 621 |
| TOTAL | $1,042 | $650 | $514 | $879 | $948 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,042 | $650 | $514 | $879 | $948 |
| Shareholders' Equity | |||||
| Common Shares | 107,079 | 103,584 | 103,584 | 100,741 | 101,407 |
| Retained earnings | -126,926 | -125,122 | -123,013 | -120,381 | -118,244 |
| Other shareholders' equity | 16,693 | 14,609 | 14,491 | 13,479 | 12,785 |
| TOTAL | $6,811 | $3,013 | $5,004 | $2,811 | $4,920 |
| Total Liabilities And Equity | $7,853 | $3,663 | $5,518 | $3,690 | $5,868 |